Silence Therapeutics Plc (SLN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 156 | 148 | 138 | 119 | 171 |
| Income taxes - deferred | 1 | 10 | 0 | N/A | N/A |
| Accounts receivable | -2,430 | -2,003 | 9,278 | -2,094 | 1,394 |
| Other Working Capital | 9,063 | -4,502 | 10,492 | -26,324 | 254 |
| Other Operating Activity | -17,681 | -15,437 | -32,217 | 3,435 | -29,026 |
| Operating Cash Flow | $-10,891 | $-21,784 | $-12,309 | $-24,864 | $-27,207 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -48 | -4 | -56 | -70 |
| Purchase Of Investment | -20,186 | -2,389 | -70,060 | -21,262 | -68,023 |
| Sale Of Investment | 71,478 | 875 | 25,683 | 91,431 | 25,981 |
| Other Investing Activity | 0 | 0 | 0 | -1,985 | 692 |
| Investing Cash Flow | $51,289 | $-1,562 | $-44,381 | $68,129 | $-41,420 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -73 |
| Common Stock Issued | 0 | 1 | 14 | -17,684 | 16,782 |
| Other Financing Activity | 0 | 0 | 0 | 9,385 | -911 |
| Financing Cash Flow | $0 | $1 | $14 | $-8,299 | $15,798 |
| Exchange Rate Effect | -106 | 198 | 232 | 6,975 | -6,703 |
| Beginning Cash Position | 41,739 | 64,886 | 121,330 | 82,906 | 138,473 |
| End Cash Position | 82,031 | 41,739 | 64,886 | 121,330 | 82,906 |
| Net Cash Flow | $40,398 | $-23,345 | $-56,676 | $34,965 | $-52,830 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,891 | -21,784 | -12,309 | -24,864 | -27,207 |
| Capital Expenditure | -3 | -48 | -4 | -56 | -70 |
| Free Cash Flow | -10,894 | -21,832 | -12,313 | -24,920 | -27,278 |